Acne Vulgaris and Hidradenitis Suppurativa
Mark S. Nestor
Alexandria B. Glass
Michael H. Gold
ACNE VULGARIS
BACKGROUND
Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit and is the most common dermatological condition in the United States. The cost of treatment exceeds $3 billion annually, and at some point, 85% of all 12- to 24-year-olds are affected.1 This condition affects both genders equally and characteristically begins during puberty, peaks at 15 to 18 years of age, and frequently resolves during early adulthood. However, many adults, with women outnumbering men, are affected by acne well into their fifties.2,3,4
PRESENTATION
Acne vulgaris is generally located in areas with numerous sebaceous glands, such as the face, neck, chest, shoulders, and upper back. The open comedo, “blackhead,” can be seen as a flat or slightly raised papule with a central opening filled with darkened keratin. The closed comedo, “whitehead,” are skin-colored papules that sometimes can be visualized better by stretching the skin. The other 2 primary lesions are papules and pustules, which are larger and more prominent. Because these are due to inflammation, they can be painful, appear edematous and/or erythematous, and occasionally discharge yellowish or serosanguineous pus. In individuals with more severe acne, these papulopustules can
enlarge to form nodules and even coalesce to form sinus tracts under the skin. Patients with acne classically have a combination of all types of lesions in various states of resolution. When the inflammatory lesions resolve, they leave behind postinflammatory hyperpigmentation, which can appear dissimilar on different skin types. In light-colored skin, a reddish purple macule is generally seen compared with a dark brown/black macule in darker skinned individuals, which can take months to disappear. Larger lesions, especially those manipulated, can leave scars, which is why early detection and treatment is essential.2,4,5
enlarge to form nodules and even coalesce to form sinus tracts under the skin. Patients with acne classically have a combination of all types of lesions in various states of resolution. When the inflammatory lesions resolve, they leave behind postinflammatory hyperpigmentation, which can appear dissimilar on different skin types. In light-colored skin, a reddish purple macule is generally seen compared with a dark brown/black macule in darker skinned individuals, which can take months to disappear. Larger lesions, especially those manipulated, can leave scars, which is why early detection and treatment is essential.2,4,5
DIAGNOSIS
Clinical Diagnosis
The diagnosis can be made clinically and is usually described as being predominately noninflammatory (open and closed comedones), inflammatory (papules and pustules), and/or nodulocystic (cysts and nodules).
Histopathology
Histopathologic examination of acne lesions correlates with clinical findings. Closed comedones appear as dilated follicular ostia impacted with keratin, bacteria, hair, and eosinophils under a thinned epithelial layer. Open comedones have a wide follicular canal with overall broader follicular expansion. Inflammatory lesions show the cystic contents ruptured into the dermis. Pustules demonstrate a folliculocentric abscess surrounded by a dense inflammatory infiltrate of lymphocytes and neutrophils. Later, a foreign body granulomatous reaction surrounds the follicle, forming scars.2,3
Subtypes
Adult Acne
Adult acne, or postadolescent acne, is acne that continues beyond the age of 25 years. It is most common in women between the ages of 25 and 50 years, and it has been estimated that 12% of women and 3% of men have acne until 44 years of age. It can occur in individuals who experienced acne as an adolescent or as their first occurrence of acne. In women, it typically presents as papules and nodules located on the lower face and jawline. The acne tends to worsen a week before menstruation, which is why hormonal therapy is often effective.2,3
Neonatal and Infantile Acne
Neonatal acne is a very common condition and occurs in more than 20% of newborns. It presents as small papules and pustules located on the face a few days to weeks after birth. There is a male predominance, and it usually spontaneously resolves within 3 months. It is thought to be caused by an inflammatory reaction to Malassezia species on the skin in combination with their active sebum excretion in the neonatal period.2,3
Infantile acne includes cases that extend past the neonatal period and new cases that begin after 6 weeks of age. Most babies present around the age of 3 to 8 months, and the acne clears within 1 to 2 years; however, some cases extend into childhood and/or through puberty. When acne persists or has an onset into childhood, a pediatric endocrinology workup may be necessary to rule out hormonal disorders and growth abnormalities. The actual cause of infantile acne may be related to genetics and/or to elevated levels of androgens, which are present until around 1 year of age.2,3
Acne Conglobata
Acne conglobata is a cystic form of acne that can be very severe. It is most commonly observed in males around 16 years old, especially athletes and bodybuilders using anabolic steroids, and can persist into adulthood. It consists of the abrupt onset of cystic lesions as well as multiple comedones, abscesses, and grouped nodules, sometimes with interconnecting sinuses under the skin. The lesions are located on the face, neck, chest, back, and buttocks and characteristically contain a thick, yellowish, blood-tinged pus that usually refills after incision and drainage. Severe scars persist after resolution of the lesion. Acne conglobata may be seen as part of the “follicular occlusion triad,” which consists of acne conglobata, dissecting cellulitis of the scalp, and hidradenitis suppurativa (HS), which will be discussed later in this chapter. Acne conglobata can also be seen with sterile pyogenic arthritis and pyoderma gangrenosum in an autosomal dominant disorder known as PAPA syndrome. This syndrome is due to a mutation in CD2 antigen binding protein 1 (CD2BP1), also known as proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1). Treatment of choice for this disorder is isotretinoin, which will be discussed in the treatment section.2,3
Acne Fulminans
Acne fulminans is another rare, but very severe, form of cystic acne that most commonly occurs in teenage boys, especially those taking anabolic steroids. Affected individuals have an abrupt occurrence of inflammatory nodules and plaques located mostly over their chest and back, with their face less involved than in acne conglobata. As the lesions resolve, they leave ragged ulcerations and scarring. In addition, unlike acne conglobata, patients typically have systemic symptoms such as fever, leukocytosis, polymyalgia, destructive arthritis, and myopathy. Osteolytic bone lesions, especially of the clavicle and sternum, are also commonly seen. Laboratory abnormalities can occur, including elevated erythrocyte sedimentation rate, proteinuria, leukocytosis, and anemia. Oral prednisone is the recommended initial therapy for this condition. For the first 4 to 8 weeks, doses of 40 to 60 mg per day are needed to decrease the inflammation. After 4 weeks of therapy, isotretinoin can be added starting at 10 to 20 mg per day and slowly increased to standard doses.2,3
SAPHO Syndrome
SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome is a chronic condition of inflammatory bone disorders that may be associated with skin findings. This can commonly present with acne fulminans. The chest wall and the mandible are the most frequent sites for musculoskeletal complaints in adults, and the long bones, particularly the tibia, are most frequent in children. Skin findings include palmoplantar pustulosis, acne conglobata, acne fulminans, pustular psoriasis, HS, dissecting cellulitis of the scalp, Sweet syndrome, and Sneddon-Wilkinson disease. The skin findings usually precede the musculoskeletal complaints but are not present at all in 15% adults and 70% of children affected by this syndrome. The most specific diagnostic tests are nuclear scans of the anterior chest wall.2
Excoriated Acne
Excoriated acne, also known as picker’s acne and acne excoriée des jeunes filles, is a condition primarily observed in young women, especially those with depression, anxiety, or obsessive-compulsive disorder. Affected patients initially develop a very mild form of acne; however, they habitually manipulate their small, sometimes nonexistent, lesions until a secondary crust forms. Linear erosions, crusts, and scars seen clinically suggest this form of acne. Psychotherapy, antidepressants, and antianxiety medications may be indicated for these individuals.2,3
Differential Diagnosis
Rosacea
Lupus
Neurodermatitis
Folliculitis
Impetigo
Seborrheic dermatitis
PATHOGENESIS
The primary lesion in acne is the comedo, and its formation is multifactorial, but primarily due to 4 main factors: hyperproliferation of keratinocytes, excess sebum production, inflammation, and the activity of Propionibacterium acnes.1 First, hyperproliferation and abnormal differentiation of the keratinocyte occurs in the infundibulum of the hair follicle. Instead of normally being shed through the follicular ostium, the keratinocytes are retained owing to increased cohesiveness. This leads to hyperkeratosis, which creates a “plug” blocking the follicular opening. Additionally, during this time, there is a surplus of sebum production due to stimulation from increased circulating androgens. This increase transpires normally during puberty. Because the follicular opening is blocked, the lower infundibulum becomes dilated with entrapped sebum. This compressed unit creates an anoxic environment leading to an overgrowth of P acnes. The combination of keratin, sebum, and P acnes continues to expand and build pressure until the pilosebaceous unit eventually bursts discharging the contents into the dermis. Then, white blood cells such as neutrophils, lymphocytes, and foreign body giant cells are able to recognize the foreign lipoproteins. They do this through toll-like receptors (TLRs), which are transmembrane receptors that help immune cells and keratinocytes recognize pathogens. P acnes increases the expression of TLR2 and TLR4 on keratinocytes and also stimulates the release of proinflammatory interleukins, such as IL-6 and IL-8, resulting in inflammatory cell migration to the area. This reaction creates inflammatory acne lesions such as papules and pustules.2,3,4,5,6
The type of inflammatory response at the affected area can also determine the type of inflammatory acne lesion seen. If neutrophils compromise the majority of
the response, observed in earlier lesions, then a pustule is formed. Neutrophils can release enzymes creating reactive oxygen species (ROS), which may correlate to lesion severity. If a mixture of lymphocytes, foreign body-type giant cells, and neutrophils are seen, then papules, nodules, and cysts are more likely to form.3
the response, observed in earlier lesions, then a pustule is formed. Neutrophils can release enzymes creating reactive oxygen species (ROS), which may correlate to lesion severity. If a mixture of lymphocytes, foreign body-type giant cells, and neutrophils are seen, then papules, nodules, and cysts are more likely to form.3
Furthermore, P acnes plays a big role in the formation of acne. These anaerobic, gram-positive, nonmotile rods are found as part of the normal skin flora and in the lower infundibulum of the hair follicle. Increased organisms are found in patients with acne; however, the amount does not correlate with disease severity. The yeast, Malassezia furfur, is also part of the normal skin flora and can promote acne formation. They contribute to the inflammatory response by releasing ROS, proinflammatory mediators, and enzymes, such as lipases, that cause to comedo rupture.3,4
Hormones have been shown to influence acne, especially potent androgens such as dehydroepiandrosterone sulfate. Androgens are produced both by the sebaceous gland and by external sources such as the gonads and adrenal glands. In addition, androgen receptors, including testosterone and 5α-dihydrotestosterone, are found on the basal layer of the sebaceous gland and the outer root sheath of the hair follicle. Androgens stimulate the sebaceous gland to grow larger and produce more sebum. Androgen levels are increased in infants from birth to 6 to 12 months of age, decreasing around 1 year of age, and then remain stable until adrenarche. At the onset of puberty (typically occurring at the age of 10-11 years for females and 11-12 years for males), elevated levels of androgens lead to increased sebum production triggering acne formation, as previously mentioned. The increase in androgens explains why acne affects the majority of adolescents during puberty. In addition, this is the reason individuals in hyperandrogenic states, such as those with XYY karyotype, polycystic ovarian syndrome, hypercortisolism, and precocious puberty, tend to have more severe, resistant acne. Areas of skin that do not respond to androgens do not develop acne. Furthermore, giving estrogens may counteract the effects of androgens. Estrogens decrease sebum production but must be given in doses higher than those required for birth control. The ways these hormones influence sebum production provide additional therapies to treat acne.2,3,4,5
The relationship between diet and acne is controversial. In recent years, some studies have found that dairy, especially high intakes of skim milk may correlate with more severe acne. Also, some believe that a high-glycemic diet may worsen acne. However, these relationships are not widely accepted by all dermatologists at this time.2,3,4,5
TREATMENT
Acne treatment has been well studied in the literature, and as a result, there are numerous approaches to helping the patient with acne. Currently, there are medical therapies (including topical and systemic medications) and physical modalities employed to treat acne. The generalized treatment algorithm is outlined in Algorithm 9.1.1.
Medical
The treatment algorithm for acne typically commences with medical therapy, including topical therapy and, when necessary, progressively incorporating oral therapy.
Topical Treatments
Retinoids. Topical retinoids are considered the first-line treatment option for acne. They work by normalizing some of the main contributors to comedo formation: hyperproliferation of keratinocytes and corneocyte cohesion. By normalizing the desquamation process of the epithelium, comedone formation is decreased and existing comedones are expelled. Retinoids also have anti-inflammatory properties owing to their ability to decrease the expression of TLRs and proinflammatory mediators. This makes them an acceptable form of monotherapy for both comedonal and inflammatory lesions. In addition, they assist in the penetration of other topical medications, which is why they are commonly combined with other products such as benzoyl peroxide and topical antibacterials.2,3,4
Topical retinoids used today include tretinoin (all-trans-retinoic acid), adapalene, and tazarotene. Tretinoin is a naturally occurring metabolite of retinol and was the first topical retinoid used for acne treatment. It works by binding in the skin to both retinoic acid receptors α (RARα) and γ (RARγ). Common concentrations prescribed are 0.025%, 0.05%, and 0.1%, and they come in cream or gel vehicles. Tretinoin is photolabile and therefore should be applied at night. It typically takes around
2 to 3 months to observe improvement and is pregnancy category C. Adapalene is a newer, synthetic retinoid that binds only to RARγ, making it less irritating than tretinoin. It comes in 0.1% and 0.3% formulations, can be applied morning or night, and is pregnancy category C. Although previously only available via prescription, the 0.1% formulation recently became US Food and Drug Administration (FDA) approved to be sold over the counter. Tazarotene is another synthetic topical retinoid that, like adapalene, selectively binds only RARγ. Even though its mechanism of action is similar, it is considered much stronger than adapalene, which also makes it more irritating. It comes in cream or gel formulations of 0.05% and 0.1% concentrations and is pregnancy category X. The main side effects observed in all retinoids is local skin irritation, erythema, and dryness, which can be lessened with every other day application, if needed, and moisturizers.2,3,7
2 to 3 months to observe improvement and is pregnancy category C. Adapalene is a newer, synthetic retinoid that binds only to RARγ, making it less irritating than tretinoin. It comes in 0.1% and 0.3% formulations, can be applied morning or night, and is pregnancy category C. Although previously only available via prescription, the 0.1% formulation recently became US Food and Drug Administration (FDA) approved to be sold over the counter. Tazarotene is another synthetic topical retinoid that, like adapalene, selectively binds only RARγ. Even though its mechanism of action is similar, it is considered much stronger than adapalene, which also makes it more irritating. It comes in cream or gel formulations of 0.05% and 0.1% concentrations and is pregnancy category X. The main side effects observed in all retinoids is local skin irritation, erythema, and dryness, which can be lessened with every other day application, if needed, and moisturizers.2,3,7
Benzoyl Peroxide. Benzoyl peroxide is a topical over-the-counter treatment that has been used for years and is considered by some providers to be a first-line treatment. It works as an antibacterial against P acnes and therefore seems to be more efficacious for inflammatory lesions compared with comedonal lesions. The advantage of using benzoyl peroxide is that there is no risk of P acnes resistance, and it can be combined with many other topical medications. Treatment is usually
once or twice daily, and preparations are made in 2.5% to 10% concentrations. It is pregnancy category C, and common side effects are local skin irritation and peeling. Of note, it is important to remind patients that this medication will bleach fabric, so washing hands thoroughly after usage, allowing it time to dry on the skin, and using white sheets and towels is recommended.2,3,4,6,7
once or twice daily, and preparations are made in 2.5% to 10% concentrations. It is pregnancy category C, and common side effects are local skin irritation and peeling. Of note, it is important to remind patients that this medication will bleach fabric, so washing hands thoroughly after usage, allowing it time to dry on the skin, and using white sheets and towels is recommended.2,3,4,6,7
Antibacterials. Topical antibacterials include the macrolides, clindamycin and erythromycin, and dapsone. They are indicated for mild to moderate acne and come in a variety of formulations. Clindamycin comes in many vehicles such as gel, lotion, solution, and foam and is prescribed in a 1% concentration. Erythromycin is used in a 2% concentration as a gel or solution. They are both pregnancy category B. Owing to the risk of antibiotic resistance, benzoyl peroxide should be used with these topical antibacterials for reasons previously mentioned. These can also be used with topical retinoids.2,3,4
Dapsone is a newer topical antibacterial that comes in gel formulations of 5% and 7.5% and is applied twice or once daily, respectively. It is pregnancy category C, and side effects include local skin irritation, mild pruritus, burning, hemolytic anemia, and yellow-orange discoloration of the skin when concomitantly used with benzoyl peroxide.2,3,7
Salicylic Acid and Azelaic Acid. Salicylic acid is a commonly used over-the-counter acne treatment found in up to 2% concentrations in acne washes, toners, and pads. It has mild anti-inflammatory action and is also a mild irritant, which helps to dry up lesions. Side effects are mild irritation, erythema, and scaling, and it is pregnancy category C.2,3
Azelaic acid is a dicarboxylic acid that can be effective for both mild inflammatory and comedonal acne. It is available as a 15% gel or foam and as a 20% cream and has anti-inflammatory, antimicrobial, and comedolytic properties. It is typically better tolerated than retinoids, may help to lighten postinflammatory hyperpigmentation, and is pregnancy category B.2,3,7
Systemic Treatments
Oral Antibiotics. Oral antibiotics have been used for decades for the treatment of moderate to severe acne. They are typically reserved for individuals with inflammatory acne, those who scar easily, those with truncal acne, and for those who do not respond to topical treatment. The most commonly prescribed antibiotics are the tetracycline derivatives, doxycycline and minocycline. These antibiotics not only inhibit the growth of P acnes but also are mainly used for their anti-inflammatory effects as well. They are dosed at 50 to 100 mg once or twice daily. The goal of therapy is to initiate patients at a high dose and decrease until they can be maintained on topical therapy. It can take up to 8 to 12 weeks to observe efficacy, and patients typically remain on therapy for 4 to 6 months. The side effect specific to doxycycline is photosensitivity; therefore, patients should be cautious in the sunlight owing to easier risk of sunburn. Also, gastrointestinal side effects are commonly observed, so patients should be instructed not to take their medication before bedtime and to swallow it with a full glass of water. Possible adverse effects of minocycline are vertigo, lupuslike syndromes, and gray-blue pigmentation in areas of inflammation, such as the teeth, gums, nails, scars, and shins. Both of these antibiotics are pregnancy category D and can stain growing teeth, which is why they are prescribed only for children greater than 8 years of age. When the tetracyclines cannot be prescribed, amoxicillin is another alternative that is safe in pregnancy, generally prescribed at 250 to 500 mg daily to up to 3 times per day. With all oral antibiotic usage, it is recommended to use topical benzoyl peroxide to decrease the risk of antibiotic resistance.2,3,4,7
Hormonal Therapy. Hormonal therapy can be very effective when treating acne in females and is generally used as a second-line treatment. It is especially useful in adult women who have acne located on the lower face and those whose acne worsens around their menstrual cycle. The main classes of medications used to treat hormonal acne are oral contraceptives and spironolactone, and they both work as antiandrogens. Oral contraceptives are effective because they block both ovarian and adrenal production of androgens. Medications such as Ortho Tri-Cyclen, Yaz, Yasmin, Estrostep, and Alesse all have proven to be effective in acne. Side effects such as nausea, abnormal menses, weight gain, breast tenderness, melasma, and increased risk of blood clots are all factors to consider when initiating treatment.2,3
Spironolactone, an aldosterone receptor antagonist, is not only used as an antihypertensive but is also effective for treating hormonal acne. It works as an androgen receptor blocker and is typically dosed at 100 mg daily, but effective doses range from 25 to 200 mg per day. Owing to feminization of the male fetus during
pregnancy, it is strongly recommended that an effective form of birth control be used with spironolactone. Other side effects are breast tenderness, headache, diuresis, dizziness, fatigue, and hyperkalemia.2,3,7
pregnancy, it is strongly recommended that an effective form of birth control be used with spironolactone. Other side effects are breast tenderness, headache, diuresis, dizziness, fatigue, and hyperkalemia.2,3,7
Isotretinoin. Oral isotretinoin (13-cis-retinoic acid) is one of the most effective treatments for acne and has been prescribed for over 25 years. It is the only medication approved by the FDA for severe cystic acne; however, providers also use it in patients with moderate to severe acne that is resistant to all other forms of treatment. After 1 course, which takes an average of 4 to 6 months, most patients can expect around an 85% improvement in their acne.1 It is dosed at 0.5 to 1 mg/kg/d taken in 1 dose or divided into 2 daily doses. It is recommended to be taken with a fatty meal to increase absorption. To obtain prolonged remission, the goal is to reach a cumulative dose of 120 to 150 mg/kg by the end of treatment. The advantage to using isotretinoin is that, in the majority of patients, remission can last years and patients can remain acne free through early adulthood. Isotretinoin therapy is not without risks and has more side effects than other acne medications. First and foremost, isotretinoin is pregnancy category X and can cause severe fetal abnormalities. Its usage is heavily regulated by the FDA (through the iPLEDGE management program), which requires monthly visits by the patient to their dermatologist during treatment. Women should use an effective form of birth control and should not become pregnant until 1 month after stopping the medication. Other disorders, such as depression and inflammatory bowel disease, have been linked to isotretinoin therapy but this connection remains controversial. Abnormal laboratory values, such as elevated lipids and liver enzymes, can occur, so regular laboratory tests are performed to monitor these changes closely. More common but less severe side effects are dose dependent and include dry skin, dry lips, dry eyes, and dry oronasal mucosa, which occur in 90% of patients.2,3,4,5